Glutathione S-transferase (GST) is a major phase II drug-metabolizing enzyme. Several isoforms of human GST as well as different
GST genetic polymorphisms are known, but limited data exists concerning the relationship between
GST polymorphisms and GST activity using 1-chloro-2,4-dinitrobenzene in human liver. To resolve this query, we analyzed the genetic polymorphisms of four main GST isoforms [GST mu 1 (GSTM1), GST theta 1 (GSTT1), GST alpha 1 (GSTA1), GST pi 1 (GSTP1)] and measured hepatic GST activity isolated from the same patients. We found that
GSTM1 null individuals have significantly lower (
P=0.0082) GST activity compared with
GSTM1 positive individuals. No significant changes in GST activity were observed in individuals with
GSTT1,
GSTA1, and
GSTP1 genotypes. Interestingly, the levels of GST activity exhibited were similar when compared with
GSTA1*
A/*
A and
GSTA1*
A/*
B, and
GSTP1*
A/*
A and
GSTP1*
A/*
B, respectively, if the genotype was
GSTM1 null. Therefore, the genotypes of
GSTA1*
A/*
B and
GSTP1*
A/*
B individuals do not significantly affect the level of hepatic GST activity. An examination of the correlation between
GST mRNA expression and GST activity subsequently revealed a significant correlation between
GSTM1 mRNA levels and GST activity (r=0.626,
P=0.007). These data are expected to facilitate research on the prediction of efficacy and safety of
GSTM1 null-mediated drug metabolism and may establish whether genetic polymorphisms of the
GST gene, specifically
GSTM1, can act as a biomarker.
View full abstract